Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-018736

Chief Commercial Officer sold 1,583 shares at $1.83 ($2,897)

  • Chief Commercial Officer acquired 5,461 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Kane Kieran · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-09 Exercise or conversion : show line 1 in the form +5,461 9,222 D
2022-05-10 Sale : show line 2 in the form −1,583 $1.83 $2,897 7,639 D
Open-market sales · 1,583 sh · avg $1.83 · $2,897

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-05-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,489 1,489 22,342 D
2022-05-09 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,972 3,972 19,859 D
Loading xslF345X03/form4.xml…